Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Filings indexed 1,210 across all filing types
Latest filing 2010-06-29 Regulatory Filings
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2010
Regulatory Filings
2010-06-29 English
Regulatory Filings 2010
Regulatory Filings
2010-05-31 Danish
Board/Management Information 2010
Board/Management Information Classification · 99% confidence The document is a 'Selskabsmeddelelse' (Company Announcement) from ALK dated May 31, 2010. The headline is 'Ændring i ledelsen i ALK' (Change in management in ALK), and the summary explicitly states the appointment of Flemming Pedersen as the new Chief Financial Officer (CFO) and member of the executive board, replacing Jutta af Rosenborg. This content directly corresponds to the definition of Board/Management Information.
2010-05-31 English
Report Publication Announcement 2010
Report Publication Announcement Classification · 99% confidence The document is a short company release (1969 characters) addressed to NASDAQ OMX Copenhagen A/S, titled 'Company release No 11/2010'. The core content announces the 'Release date of three-month interim report (Q1) 2010 for ALK' scheduled for May 6, 2010. It also mentions that the related presentation will be available shortly before the conference call begins and provides details for the call. Because the document is an announcement about the publication of an interim report and associated materials, rather than the comprehensive report itself, it fits the definition of a Report Publication Announcement (RPA). It is not the Interim Report (IR) itself, nor is it a general Regulatory Filing (RNS) given the specific nature of announcing a report release.
2010-04-28 English
Regulatory Filings 2010
Regulatory Filings
2010-04-28 Danish
Regulatory Filings 2010
Regulatory Filings
2010-04-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.